Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
271.86
Nov 16 • 3:59 PM ET Dollar change-3.29 Percentage change(-1.20%)
Aftermarket Close
271.80
Aftermarket • 5:39 PM ET Dollar change-0.06 Percentage change(-0.02%)
Index
RUI
Market Cap
17.68B
Enterprise Value
-
Income
1.71B
Sales
27.37B
Book/sh
178.90
Cash/sh
-
Employees
4300
IPO
May 04, 1993
P/E
10.51
Forward P/E
8.92
PEG
0.69
P/S
0.65
P/B
1.52
P/C
-
P/FCF
3.18
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
0.46
LT Debt/Eq
0.46
Option/Short
Yes / Yes
EPS (ttm)
25.88
EPS next Y
30.47
EPS next Q
7.18
EPS this Y
36.78%
EPS next Y
-1.96%
EPS next 5Y
12.96%
EPS past 3/5Y
32.33% 22.91%
Sales past 3/5Y
13.48% 10.18%
EPS Y/Y TTM
99.93%
Sales Y/Y TTM
22.58%
EPS Q/Q
82.97%
Sales Q/Q
22.15%
Insider Own
0.32%
Insider Trans
-8.71%
Inst Own
101.31%
Inst Trans
0.14%
ROA
1.12%
ROE
13.90%
ROIC
10.10%
Gross Margin
-
Oper. Margin
9.47%
Profit Margin
6.25%
SMA20
1.69%
SMA50
5.43%
SMA200
18.87%
Trades
Shs Outstand
65.04M
Shs Float
64.84M
52W High
277.15 -1.91%
52W Low
182.73 48.78%
Volatility
1.96% 2.05%
ATR (14)
5.85
RSI (14)
60.33
Beta
0.40
Rel Volume
1.29
Avg Volume
398.32K
Volume
513,140
Perf Week
1.92%
Perf Month
1.92%
Perf Quarter
11.23%
Perf Half Y
26.43%
Perf YTD
33.62%
Perf Year
44.06%
Perf 3Y
72.60%
Perf 5Y
143.14%
Perf 10Y
125.99%
Prev Close
275.15
Price
271.86
Change %
-1.20%
Consensus
Buy
Avg. Price Target
$294.38
Implied Upside
+8.3%
Analysts12incl. previous ratings
Rating Distribution8 Buy · 3 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 28, 2026Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight$295+8.5%
Oct 17, 2025Downgrade
RJF logoRRaymond James
Mkt Perform → Underperform
May 23, 2025Downgrade
RJF logoRRaymond James
Strong Buy → Mkt Perform
Apr 02, 2025Upgrade
JPM logoJJP Morgan
Neutral → Overweight$237-12.8%
Apr 02, 2025Downgrade
UBS logoUUBS
Buy → Neutral$216-20.5%
Oct 09, 2024Initiated
TD logoTTD Cowen
Hold$235-13.6%
Sep 05, 2024Initiated
BCS logoBBarclays
Overweight$255-6.2%
Dec 11, 2023Upgrade
JEF logoJJefferies
Hold → Buy$171 → $189-30.5%
Jun 23, 2023Downgrade
JEF logoJJefferies
Buy → Hold$170 → $160-41.1%
Jun 07, 2023Initiated
RJF logoRRaymond James
Strong Buy$199-26.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHENG TONY KIN SHUNPresident and CEONov 10 '26Option Exercise129.723,280425,48246,688Nov 13 04:07 PM
Ozeki ArthurEVP, Head of Asia PacificNov 10 '26Option Exercise129.721,401181,73814,437Nov 13 04:07 PM
Wainwright SimonExec. Advisor to CEONov 11 '26Option Exercise129.721,818235,83116,947Nov 13 04:06 PM
PORTER JONATHANEVP, Global Chief Risk OfficerNov 10 '26Sale271.533,8521,045,93611,033Nov 13 08:38 AM
PORTER JONATHANOfficerNov 10 '26Proposed Sale271.533,8521,045,936Nov 10 01:05 PM
PORTER JONATHANEVP, Global Chief Risk OfficerAug 12 '26Sale246.308,5892,115,46014,885Aug 17 08:01 PM
HERRMANN RONALDExecutive Vice PresidentAug 11 '26Option Exercise159.6910,8021,724,9868,698Aug 13 06:33 PM
PORTER JONATHANEVP, Global Chief Risk OfficerAug 11 '26Option Exercise123.2117,3112,132,97324,928Aug 13 06:33 PM
PORTER JONATHANOfficerAug 12 '26Proposed Sale246.308,5892,115,460Aug 12 12:16 PM
BROOKS MARK JFormer OfficerJun 15 '26Proposed Sale212.92781166,288Jun 15 02:40 PM
Hayden John W.EVP, ControllerMay 20 '26Option Exercise129.801,867242,33722,816May 22 06:15 PM
Hayden John W.EVP, ControllerMay 20 '26Sale214.9541488,98920,949May 22 06:15 PM
Hayden John W.OfficerMay 20 '26Proposed Sale214.9541488,989May 20 01:48 PM
HERRMANN RONALDExecutive Vice PresidentMay 14 '26Sale210.587,0001,474,0423,938May 18 04:56 PM
HERRMANN RONALDOfficerMay 14 '26Proposed Sale210.587,0001,474,042May 14 12:30 PM
Cockrill LauraEVP & Chief Strategy OfficerMar 12 '26Option Exercise205.001,079221,1953,125Mar 16 09:12 PM
Ozeki ArthurEVP, Head of Asia PacificMar 12 '26Option Exercise205.002,689551,24513,036Mar 16 09:12 PM
Hayden John W.EVP, ControllerMar 12 '26Option Exercise205.002,252461,66021,605Mar 16 09:12 PM
PORTER JONATHANEVP, Global Chief Risk OfficerMar 12 '26Option Exercise205.005,4561,118,48017,806Mar 16 09:12 PM
CHENG TONY KIN SHUNPresident and CEOMar 12 '26Option Exercise205.0017,3883,564,54050,123Mar 16 09:11 PM
HERRMANN RONALDEVPMar 12 '26Option Exercise205.006,5761,348,08013,795Mar 16 09:11 PM
BARBI LESLIEEVP, Chief Investment OfficerMar 12 '26Option Exercise205.008,4301,728,15024,288Mar 16 09:11 PM
Wainwright SimonExec. Advisor to CEOMar 12 '26Option Exercise205.002,239458,99516,182Mar 16 09:11 PM
Galvin CormacEVP, Head of EMEAMar 12 '26Option Exercise205.001,496306,6804,236Mar 16 09:11 PM
Kleeman RaymondEVP, Chief HR OfficerMar 12 '26Option Exercise205.004,553933,36512,250Mar 16 09:11 PM
PORTER JONATHANEVP, Global Chief Risk OfficerFeb 11 '26Option Exercise139.341,324184,48212,512Feb 13 04:36 PM
HERRMANN RONALDEVPFeb 11 '26Option Exercise106.532,401255,7797,934Feb 12 05:31 PM
Wainwright SimonExec. Advisor to CEOFeb 10 '26Option Exercise93.532,671249,81914,659Feb 11 06:10 PM
CHENG TONY KIN SHUNPresident and CEOFeb 10 '26Option Exercise93.534,152388,33734,521Feb 11 06:07 PM
Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. It operates through the following segments: U.S. and Latin America, Canada, Europe, Middle East, and Africa, Asia Pacific, and Corporate and Other. The U.S. and Latin America segment markets individual and group life and health reinsurance to domestic clients for a variety of products through yearly renewable term agreements, coinsurance, and modified coinsurance. The Canada segment offers individual life reinsurance, and, to a lesser extent, creditor, group life and health, critical illness, and disability reinsurance, through yearly renewable term and coinsurance agreements. The Europe, Middle East, and Africa segment serves individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage that provides a benefit in the event of the diagnosis of a pre-defined critical illness, and underwritten annuities. The Asia Pacific segment consists of individual and group life and health reinsurance, critical illness coverage, disability, and superannuation through yearly renewable term and coinsurance agreements. The Corporate and Other segment consists of investment income from unallocated invested assets, investment related gains, and losses and service fees. The company was founded in 1973 and is headquartered in Chesterfield, MO.
PresidentMr. Tony Cheng F.S.A.
EVPMs. My Chi Christine To
EVPMr. Ronald Paul Herrmann CFP
Executive VP & CFOMs. Laura Kathleen Cockrill
C.F.A.Mr. Jayson Reagan Bronchetti C.A.I.A.